Plain-English translation of NCT06570798 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two new medications called and to see if they can help people with severe lupus or rheumatoid arthritis whose disease hasn't improved with standard treatments. is given as an IV infusion (through a vein), while is given as an injection under the skin. The trial will measure whether these medications are safe and whether they reduce disease activity.
Some patients with lupus or rheumatoid arthritis don't respond well enough to current medications, leaving them with ongoing pain, inflammation, and organ damage. Researchers are testing this medication to see if a different approach to controlling the immune system might work better for these patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either intravenous infusions or subcutaneous injections of the new medication at scheduled visits over several weeks or months. You will have blood tests and clinical assessments to monitor how well the medication is working and check for side effects. The exact schedule depends on which part of the trial you are in, but you should expect multiple clinic visits and regular follow-up monitoring to track your disease activity and safety.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States